Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 26-Apr-24 9:01 PM View:  | Roivant Sciences Ltd. (ROIV) | 24-Apr-24 | Grant | 1,146 | -- | -- | 5% 21.54K to 22.68K | |
| 26-Apr-24 9:01 PM View: | Roivant Sciences Ltd. (ROIV) | 24-Apr-24 | Payment of Exercise | 123 | $10.90 | $1,340.70 | (< 1%) 22.68K to 22.56K | |
| 12-Feb-24 8:22 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 12-Feb-24 | Sale (Planned) | 2,573 | $11.44 | $29,435.10 | (< 1%) 454.02K to 451.45K | |
| 05-Feb-24 7:12 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 02-Feb-24 | Sale (Planned) | 8,669 | $11.54 | $100,040.00 | (2%) 462.69K to 454.02K | |
| 05-Feb-24 7:12 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 01-Feb-24 | Grant | 75,000 | -- | -- | 19% 387.69K to 462.69K | |
| 23-Jan-24 9:00 PM View: | Roivant Sciences Ltd. (ROIV) | 19-Jan-24 | Grant | 1,207 | -- | -- | 6% 20.33K to 21.54K | |
| 18-Oct-23 9:30 PM View: | Roivant Sciences Ltd. (ROIV) | 16-Oct-23 | Grant | 1,226 | -- | -- | 6% 19.11K to 20.33K | |
| 06-Oct-23 7:18 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 04-Oct-23 | Sale (Planned) | 5,482 | $19.50 | $106,926.00 | (1%) 393.17K to 387.69K | |
| 14-Sep-23 9:31 PM View: | Roivant Sciences Ltd. (ROIV) | 12-Sep-23 | Grant | 17,825 | -- | -- | 1393% 1.28K to 19.11K | |
| 06-Jul-23 9:30 PM View: | Roivant Sciences Ltd. (ROIV) | 03-Jul-23 | Grant | 1,280 | -- | -- | 100% 0 to 1.28K | |
| 14-Feb-23 7:10 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 14-Feb-23 | Sale (Planned) | 5,227 | $19.98 | $104,411.00 | (1%) 397.27K to 392.05K | |
| 14-Feb-23 7:10 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 13-Feb-23 | Sale (Planned) | 2,624 | $20.42 | $53,593.60 | (< 1%) 399.9K to 397.27K | |
| 01-Feb-23 7:07 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 01-Feb-23 | Grant | 101,957 | -- | -- | 34% 297.94K to 399.9K | |
| 03-Oct-22 6:42 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 03-Oct-22 | Grant | 50,000 | -- | -- | 20% 247.54K to 297.54K | |
| 05-Apr-22 6:53 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 04-Apr-22 | Sale (Planned) | 17,080 | $50.09 | $855,522.00 | (6%) 264.49K to 247.41K | |
| 23-Feb-22 10:00 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 23-Feb-22 | Sale (Planned) | 1,913 | $49.10 | $93,920.80 | (< 1%) 266.41K to 264.49K | |
| 14-Feb-22 9:09 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 10-Feb-22 | Grant | 16,405 | -- | -- | 7% 250.0K to 266.41K | |
| 04-Oct-21 9:16 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 02-Oct-21 | Payment of Exercise | 17,080 | $67.13 | $1,146,580.00 | (6%) 267.08K to 250.0K | < 1% |
| 20-Aug-21 12:59 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 19-Aug-21 | Market Purchase | 8,285 | $52.00 | $430,800.00 | 3% 258.4K to 266.69K | < 1% |
| 20-Aug-21 12:59 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 18-Aug-21 | Market Purchase | 1,326 | $52.00 | $68,948.00 | < 1% 257.07K to 258.4K | < 1% |
| 06-Jul-21 10:00 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 01-Jul-21 | Market Sale (Planned) | 3,083 | $51.27 | $158,054.00 | (1%) 260.16K to 257.07K | 6% |
| 02-Jun-21 8:26 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 01-Jun-21 | Market Sale (Planned) | 3,083 | $54.05 | $166,641.00 | (1%) 263.24K to 260.16K | < 1% |
| 05-May-21 4:27 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 03-May-21 | Market Sale (Planned) | 3,083 | $59.24 | $182,635.00 | (1%) 266.32K to 263.24K | 5% |
| 06-Apr-21 5:46 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 05-Apr-21 | Market Sale (Planned) | 17,107 | $43.39 | $742,323.00 | (6%) 283.43K to 266.32K | < 1% |
| 03-Mar-21 4:35 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 01-Mar-21 | Market Sale (Planned) | 3,083 | $41.67 | $128,482.00 | (1%) 286.51K to 283.43K | (4%) |
| 16-Feb-21 7:05 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 11-Feb-21 | Grant | 15,000 | -- | -- | 6% 271.51K to 286.51K | |
| 03-Feb-21 5:56 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 01-Feb-21 | Market Sale (Planned) | 3,083 | $37.56 | $115,805.00 | (1%) 274.6K to 271.51K | (10%) |
| 06-Jan-21 8:24 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 04-Jan-21 | Market Sale (Planned) | 3,083 | $51.91 | $160,034.00 | (1%) 277.68K to 274.6K | (< 1%) |
| 08-Dec-20 8:38 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 07-Dec-20 | Sale (Planned) | 6,464 | $53.52 | $345,963.00 | (2%) 284.14K to 277.68K | |
| 08-Dec-20 8:38 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 04-Dec-20 | Sale (Planned) | 7,220 | $50.98 | $368,097.00 | (2%) 291.36K to 284.14K | |
| 03-Dec-20 5:56 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 02-Dec-20 | Sale (Planned) | 3,083 | $51.47 | $158,681.00 | (1%) 294.45K to 291.36K | |
| 25-Nov-20 8:35 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 23-Nov-20 | Sale (Planned) | 3,083 | $46.58 | $143,614.00 | (1%) 297.53K to 294.45K | |
| 09-Apr-20 4:33 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 07-Apr-20 | Grant | 147,394 | -- | -- | 113% 130.13K to 277.53K | |
| 25-Nov-20 8:35 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 07-Apr-20 | Purchase | 20,000 | $18.00 | $360,000.00 | 7% 277.53K to 297.53K |